The Proto-Oncogene LRF Is Under Post-Transcriptional Control of MiR-20a: Implications for Senescence

View/ Open
Author
Poliseno, Laura
Pitto, Letizia
Simili, Marcella
Mariani, Laura
Riccardi, Luisa
Ciucci, Alessia
Rizzo, Milena
Evangelista, Monica
Mercatanti, Alberto
Rainaldi, Giuseppe
Published Version
https://doi.org/10.1371/journal.pone.0002542Metadata
Show full item recordCitation
Poliseno, Laura, Letizia Pitto, Marcella Simili, Laura Mariani, Luisa Riccardi, Alessia Ciucci, Milena Rizzo, Monica Evangelista, Alberto Mercatanti, Pier Paolo Pandolfi, and Giuseppe Rainaldi. 2008. The proto-oncogene LRF Is under post-transcriptional control of MiR-20a: Implications for senescence. PLoS ONE 3(7): e2542.Abstract
MicroRNAs (miRNAs) are short 20–22 nucleotide RNA molecules that act as negative regulators of gene expression via translational repression: they have been shown to play a role in development, proliferation, stress response, and apoptosis. The transcriptional regulator LRF (Leukemia/lymphoma Related Factor) has been shown to prevent p19ARF transcription and consequently to inhibit senescence in mouse embryonic fibroblasts (MEF). Here we report, for the first time, that LRF is post-transcriptionally regulated by miR-20a. Using a gene reporter assay, direct interaction of miR-20a with the LRF 3′UTR is demonstrated. To validate the interaction miR-20a/3′UTR LRF miR-20a was over-expressed, either by transient transfection or retroviral infection, in wild type mouse embryo fibroblasts and in LRF-null MEF derived from LRF knock-out mice. We observed LRF decrease, p19ARF increase, inhibition of cell proliferation and induction of senescence. The comparison of miR-20a activity in wt and LRF-null MEF indicates that LRF is the main mediator of the miR-20a-induced senescence and that other targets are cooperating. As LRF down-regulation/p19ARF induction is always accompanied by E2F1 down-regulation and increase of p16, we propose that all these events act in synergy to accomplish miR-20a-induced senescence in MEF. Senescence has been recently revaluated as a tumor suppressor mechanism, alternative to apoptosis; from this point of view the discovery of new physiological “senescence inducer” appears to be promising as this molecule could be used as anticancer drug.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2435600/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:4820731
Collections
- HMS Scholarly Articles [17734]
Contact administrator regarding this item (to report mistakes or request changes)